Envista (NYSE:NVST) reports Q3 2026 in line with expectations
Envista reported Q3 2026 revenue of $691.5M, matching estimates, and adjusted EPS of $0.40, beating estimates by 12.4%. Adjusted EBITDA was $106M, an 8.9% beat. Management raised full-year adjusted EPS guidance to $1.56. Operating margin increased to 74.5%, while free cash flow declined to -$16.1M.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance lift are likely to generate short‑term buying interest, though negative free cash flow could limit upside.
Market read
First earnings report of the quarter; provides fresh data for traders and analysts covering health‑care equipment.
What to watch
Operating margin improvement may be unsustainable if revenue growth slows.
Background
Envista (NVST) is a provider of dental and orthodontics equipment. The company posted Q3 2026 results and raised its full‑year EPS outlook.
Ticker impact
Envista reported Q3 2026 results in line with expectations and raised full-year EPS guidance.
likely modest price appreciation as market prices in the EPS guidance increase
Beat on adjusted EPS and EBITDA, plus a 2.3% EPS guidance lift, typically supports a short‑term rally.
Market effects
Dental and orthodontics equipment sector may see slight uplift from Envista's guidance raise.
U.S. market participants focused on health‑care equipment earnings.
Limited to investors tracking U.S. health‑care equipment stocks.
Counterpoint
Free cash flow turned negative, which could temper enthusiasm despite earnings beat.
Key entities
- CompanyEnvista
Dental and orthodontics equipment manufacturer (NYSE:NVST).
